Physician profile
Daniel G Dichristina
NPI 1689642456
$7,543.49
in general payments reported to CMS, 2019-2025
16 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,432 · 2020: $363 · 2021: $584 · 2022: $573 · 2023: $532 · 2024: $677 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,262.31 | 2019-2025 | Pangea, T2 Alpha, Hoffmann |
| Arthrex, INC. | $1,709.00 | 2019 | |
| Prodigy Surgical Distribution, INC. | $1,172.56 | 2019 | |
| Smith+Nephew, INC. | $397.42 | 2019-2024 | Evos, Trigen Intertan, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $215.80 | 2019-2025 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $187.85 | 2022-2024 | Exparel, Zilretta, Iovera |
| Fidia Pharma USA INC. | $150.60 | 2019-2025 | Hymovis |
| Djo, LLC | $104.40 | 2019-2021 | |
| Nevro Corp. | $67.59 | 2024 | Senza |
| Sanofi-Aventis U.S. LLC | $63.30 | 2019-2023 | |
| Horizon Therapeutics Plc | $61.26 | 2019-2021 | |
| Bioventus LLC | $48.14 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $40.95 | 2021 | |
| Zyla Life Sciences, INC. | $29.01 | 2020 | |
| Medtronic, INC. | $19.43 | 2025 | Stealthstation S8 Platform |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $13.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dichristina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.